OPRX News and Press, OptimizeRx Corporation From 02/27/20

OptimizeRx (NASDAQ: OPRX ): Q4 Non-GAAP EPS of -$0.03 misses by $0.04 ; GAAP EPS of -$0.14 misses by $0.03 . More news on: OptimizeRx Corporation, Earnings news and commentary, Consumer stocks news, , Read more ...

ROCHESTER, Mich., Feb. 27, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, reported results for the fourth quarter and year ended December 31, 2019, with all comparisons to the same year-ago ...

ROCHESTER, Mich., Feb. 19, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, will hold a conference call on Thursday, February 27, 2020 at 4:30 p.m. Eastern time to discuss results for the fourth...

ROCHESTER, Mich., Feb. 18, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has launched its first health technology solution from OptimizeRx Innovation Lab, aimed at increasing speed to therapy...

OptimizeRx (NASDAQ: OPRX) was featured in a recent Equity Research Report Published by Roth Capital Partners, LLC. The report reads, “OPRX today announced its largest ever Enterprise win. With a ‘multi-million dollar’ annual revenue value, we view this as a harbinger of re...

ROCHESTER, Mich., Jan. 29, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has sealed its largest ever enterprise deal for 12 months of access to its platform and core set of solutions. &#...

OptimizeRx Corporation (OPRX) is a healthcare IT company focused on improving messaging between manufacturers, patients, payors and doctors. OPRX's first major product, financial messaging, allowed it to penetrate the healthcare communications space. Since then, the company has added 3 additio...

ROCHESTER, Mich., Dec. 09, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health solutions for pharmaceutical companies, payers, medtech and medical associations, reported its sales pipeline, which is comprised of outstanding request for proposal...

OptimizeRx Corporation (OPRX) Q3 2019 Earnings Conference Call November 5, 2019, 04:30 PM ET Company Participants William Febbo - CEO Stephen Silvestro - CCO Miriam Paramore - President Doug Baker - CFO Conference Call Participants Andrew D'Silva - B. Riley FBR Richard ...

Fluidigm (NASDAQ: FLDM ) -31%  on Q3 results . More news on: Fluidigm Corporation, Plantronics, Inc., Amneal Pharmaceuticals, Inc., Stocks on the move, Read more ...